MIMMI, SELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.511
EU - Europa 797
AS - Asia 720
SA - Sud America 118
AF - Africa 11
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.164
Nazione #
US - Stati Uniti d'America 1.441
SG - Singapore 423
IT - Italia 422
CN - Cina 170
DE - Germania 118
BR - Brasile 104
FI - Finlandia 61
SE - Svezia 58
CA - Canada 55
GB - Regno Unito 43
IN - India 30
VN - Vietnam 22
FR - Francia 19
HK - Hong Kong 17
KR - Corea 14
PL - Polonia 11
MX - Messico 10
ES - Italia 9
JP - Giappone 9
NL - Olanda 9
RO - Romania 9
CZ - Repubblica Ceca 8
ZA - Sudafrica 7
BD - Bangladesh 6
UA - Ucraina 6
PT - Portogallo 5
RU - Federazione Russa 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
ID - Indonesia 4
CL - Cile 3
GR - Grecia 3
SA - Arabia Saudita 3
TR - Turchia 3
AT - Austria 2
CO - Colombia 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PW - Palau 1
SR - Suriname 1
UZ - Uzbekistan 1
Totale 3.164
Città #
Dallas 324
Singapore 221
Chandler 167
Munich 92
Santa Clara 84
Catanzaro 81
Hefei 74
Milan 66
Lawrence 60
Princeton 60
Ashburn 57
Turku 48
Ottawa 31
Wilmington 30
Seattle 29
London 28
Boardman 27
Chicago 20
Des Moines 20
Los Angeles 17
Rome 17
Hong Kong 15
Napoli 14
Brooklyn 13
Helsinki 12
São Paulo 12
Shanghai 11
Taranto 11
Augusta 9
Beijing 9
Montreal 9
Naples 9
Redmond 9
New York 8
Olomouc 8
Redwood City 8
Foggia 7
Ho Chi Minh City 7
Paris 7
Seoul 7
Guangzhou 6
Marano 6
Modena 6
Norwalk 6
Pune 6
Warsaw 6
Chennai 5
Hanover 5
Providence 5
San Francisco 5
San Jose 5
Stockholm 5
Teresina 5
The Dalles 5
Atlanta 4
Boston 4
Edmonton 4
Heidesheim 4
Johannesburg 4
Latina 4
Padova 4
Reggio Calabria 4
Shenzhen 4
Tokyo 4
Târgu Mureş 4
Washington 4
Xi'an 4
Amsterdam 3
Columbus 3
Council Bluffs 3
Crosia 3
Derby 3
Dubai 3
Felgueiras 3
Ferrara 3
Florence 3
Hanoi 3
Huddinge 3
Huế 3
Lamezia Terme 3
Las Vegas 3
Mexico City 3
Mumbai 3
Redondo Beach 3
Rio de Janeiro 3
Toronto 3
Villanova d'Asti 3
Wuhan 3
Adrano 2
Auckland 2
Aversa 2
Bagnara Calabra 2
Bari 2
Belgrade 2
Betim 2
Birmingham 2
Bogotá 2
Bonn 2
Campinas 2
Can Tho 2
Totale 1.953
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 123
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 88
A Candidate multi-targeting approach to block the CD98hc oncoprotein 86
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 83
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 72
PEPTIDI E LORO USI 71
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 71
A novel phage display based platform for exosome diversity characterization 69
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 64
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 63
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 62
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 62
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 61
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 61
Crucial role for IBtk in the survival and maintenance of mature B cells 61
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 59
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 59
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 57
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 55
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 51
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 51
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 49
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 47
Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays 47
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 46
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 46
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 46
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 45
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 45
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 44
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 44
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 44
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 43
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 43
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 42
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 41
PEPTIDE AND USES THEREO 41
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 40
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 40
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 40
Phage Display: An Overview in Context to Drug Discovery 39
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 39
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 39
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 39
Phage Display: An Overview in Context to Drug Discovery 38
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 38
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 37
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 36
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 36
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 36
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 36
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 35
Belantamab mafodotin in multiple myeloma 34
Insights into Thymus Development and Viral Thymic Infections 34
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 34
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 33
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 33
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 32
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 29
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 28
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 26
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 25
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 24
Peptide-guided targeting of GPR55 for anti-cancer therapy. 24
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 23
IN VIVO TUMOR TARGETING BY IDIOTYPE-SPECIFIC PEPTIDES 21
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 20
Peptide-guided targeting of GPR55 for anti-cancer therapy 19
Isatuximab in multiple myeloma 18
Idiotype-specific peptides as tools for the specific delivery of therapeutic compounds into tumors 18
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 18
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 17
PTPRJ negatively modulates CD98hc-CD147 complex activity in A549 lung cancer cells 14
Peptide-Guided Targeting Of Gpr55 For New Therapeutic Strategies Of Cance 14
null 10
null 6
null 2
Totale 3.266
Categoria #
all - tutte 32.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 5 5 26 16 2 33 37 18 10
2021/2022268 6 2 13 56 20 12 15 60 19 34 29 2
2022/2023559 122 26 38 23 52 37 7 53 108 38 41 14
2023/2024312 59 38 31 23 21 65 6 10 6 6 17 30
2024/20251.042 130 39 46 38 98 104 27 26 145 25 146 218
2025/2026762 150 218 370 24 0 0 0 0 0 0 0 0
Totale 3.266